910575-63-2

Basic information

• Product Name: 2-Propenoic acid, 2-(acetylamino)-3-[3-chloro-5-methyl-4-(phenylmethoxy)phenyl]-, methyl ester
• CAS NO: 910575-63-2
• Molecular Formula: C20H20ClNO4
• Molecular Weight: 373.836
• Mol File: 910575-63-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Propenoic acid, 2-(acetylamino)-3-[3-chloro-5-methyl-4-(phenylmethoxy)phenyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenoic acid, 2-(acetylamino)-3-[3-chloro-5-methyl-4-(phenylmethoxy)phenyl]-, methyl ester(910575-63-2)
• EPA Substance Registry System: 2-Propenoic acid, 2-(acetylamino)-3-[3-chloro-5-methyl-4-(phenylmethoxy)phenyl]-, methyl ester(910575-63-2)

Safety Data

• Hazardous Substances Data: 910575-63-2(Hazardous Substances Data)

Upstream product

• 178043-38-4 2-benzyloxy-5-bromo-1-chloro-3-methyl-benzene 
• 35356-70-8 Methyl 2-acetamidoacrylate 

Downstream Products

• 910575-67-6 (R)-3-(3-chloro-4-hydroxy-5-methyl-phenyl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester 
• 910575-68-7 (R)-3-(3-chloro-4-hydroxy-5-methyl-phenyl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid 
• 910575-65-4 (R)-2-acetylamino-3-(3-chloro-4-hydroxy-5-methyl-phenyl)-propionic acid methyl ester 
• 910575-66-5 (R)-2-amino-3-(3-chloro-4-hydroxy-5-methyl-phenyl)-propionic acid methyl ester 
• 910575-69-8 3-(4-benzyloxy-3-chloro-5-methyl-phenyl)-2-oxo-propionic acid 
• 910575-64-3 2-acetylamino-3-(3-chloro-4-hydroxy-5-methyl-phenyl)-propionic acid methyl ester 

Relevant articles and documents

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

The present invention relates to the CGRP antagonists of general formula I wherein R1, R2, R3 and R4 are as defined in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I wherein one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, their use and processes for preparing them.